Spruce Biosciences, Inc.
SPRBD
$8.20
-$0.30-3.53%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -100.06% | -49.49% | |||
| Gross Profit | 100.06% | 47.80% | |||
| SG&A Expenses | -14.58% | 10.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -81.42% | -41.50% | |||
| Operating Income | 81.42% | 39.80% | |||
| Income Before Tax | 85.28% | 40.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 85.28% | 40.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 85.28% | 40.40% | |||
| EBIT | 81.42% | 39.80% | |||
| EBITDA | 81.46% | 39.80% | |||
| EPS Basic | 85.41% | 43.72% | |||
| Normalized Basic EPS | 85.41% | 43.72% | |||
| EPS Diluted | 85.41% | 43.72% | |||
| Normalized Diluted EPS | 85.41% | 43.72% | |||
| Average Basic Shares Outstanding | 0.89% | 5.89% | |||
| Average Diluted Shares Outstanding | 0.89% | 5.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||